Skip to Content
Merck
  • Lawsone dimerization in cobalt(III) complexes toward the design of new prototypes of bioreductive prodrugs.

Lawsone dimerization in cobalt(III) complexes toward the design of new prototypes of bioreductive prodrugs.

Inorganic chemistry (2013-01-25)
Francisco L S Bustamante, Julia M Metello, Frederico A V de Castro, Carlos B Pinheiro, Marcos D Pereira, Mauricio Lanznaster
ABSTRACT

Dimerization of lawsone occurs upon reaction with Co(BF(4))(2)·6H(2)O and N,N'-bis(pyridin-2-ylmethyl)ethylenediamine (py(2)en) to produce the mononuclear complex [Co(III)(bhnq)(py(2)en)]BF(4)·H(2)O (1). This complex has been investigated as a prototype of a bioreductive prodrug, where the bhnq(2-) ligand acts as a model for cytotoxic naphthoquinones. Cyclic voltammetry data in aqueous solution have shown a quasi-reversible Co(III)/Co(II) process at E(1/2) = -0.26 V vs Fc/Fc(+). Reactivity studies revealed the dissociation of bhnq(2-) from the complex upon reduction of 1 with ascorbic acid, and a dependence of the reaction rate on the oxygen concentration suggests the occurrence of redox cycling.